Richard Kendall

Person

Thousand Oaks, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitor of vascular endothelial cell growth factor
- Patent number 8,034,772
- Issue date Oct 11, 2011
- Merck Sharp & Dohme Corp.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitor of vascular endothelial cell growth factor
- Patent number 7,071,159
- Issue date Jul 4, 2006
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,841,367
- Issue date Jan 11, 2005
- Merck & Co., Inc.
- Richard L. Kendall
- G01 - MEASURING TESTING
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,841,382
- Issue date Jan 11, 2005
- Merck & Co., Inc.
- Richard L. Kendall
- G01 - MEASURING TESTING
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,380,203
- Issue date Apr 30, 2002
- Merck & Co., Inc.
- Mark T. Bilodeau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gene therapy for inhibition of angiogenesis
- Patent number 6,375,929
- Issue date Apr 23, 2002
- Merck & Co., Inc.
- Kenneth A. Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,359,115
- Issue date Mar 19, 2002
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,235,741
- Issue date May 22, 2001
- Merck & Co., Inc.
- Mark T. Bilodeau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Angiogenesis inhibitors
- Patent number 6,228,871
- Issue date May 8, 2001
- Merck & Co., Inc.
- Mark E. Fraley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human receptor tyrosine kinase, KDR
- Patent number 6,204,011
- Issue date Mar 20, 2001
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitor of vascular endothelial cell growth factor
- Patent number 5,861,484
- Issue date Jan 19, 1999
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding a soluble VEGF inhibitor
- Patent number 5,712,380
- Issue date Jan 27, 1998
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Use Of N-(4-((3-(2-Amino-4-Pyrimidinyl)-2-Pyridinyl)Oxy)Phenyl)-4-(...
- Publication number 20120028917
- Publication date Feb 2, 2012
- Amgen Inc.
- Marc PAYTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ang2 and Vegf Inhibitor Combinations
- Publication number 20090304694
- Publication date Dec 10, 2009
- Amgen Inc.
- Jonathan Oliner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of vascular endothelial cell growth factor
- Publication number 20090247460
- Publication date Oct 1, 2009
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of vascular endothelial cell growth factor
- Publication number 20070010442
- Publication date Jan 11, 2007
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
In vivo methods of determining activity of receptor-type kinase inh...
- Publication number 20040101478
- Publication date May 27, 2004
- Kenneth A Thomas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitor of vascular endothelial cell growth factor
- Publication number 20030120038
- Publication date Jun 26, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human receptor tyrosine kinase, KDR
- Publication number 20030055239
- Publication date Mar 20, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human receptor tyrosine kinase, KDR
- Publication number 20030032160
- Publication date Feb 13, 2003
- Merck & Co., Inc.
- Richard L. Kendall
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Gene therapy for stimulation of angiogenesis
- Publication number 20020065240
- Publication date May 30, 2002
- Merck & Co., Inc.
- Kenneth A. Thomas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Richard Kendall

Person

Patents Grantslast 30 patents

Inhibitor of vascular endothelial cell growth factor

Inhibitor of vascular endothelial cell growth factor

Human receptor tyrosine kinase, KDR

Human receptor tyrosine kinase, KDR

Angiogenesis inhibitors

Gene therapy for inhibition of angiogenesis

Human receptor tyrosine kinase, KDR

Angiogenesis inhibitors

Angiogenesis inhibitors

Human receptor tyrosine kinase, KDR

Inhibitor of vascular endothelial cell growth factor

DNA encoding a soluble VEGF inhibitor

Patents Applicationslast 30 patents

Use Of N-(4-((3-(2-Amino-4-Pyrimidinyl)-2-Pyridinyl)Oxy)Phenyl)-4-(...

Ang2 and Vegf Inhibitor Combinations

Inhibitor of vascular endothelial cell growth factor

Inhibitor of vascular endothelial cell growth factor

In vivo methods of determining activity of receptor-type kinase inh...

Inhibitor of vascular endothelial cell growth factor

Human receptor tyrosine kinase, KDR

Human receptor tyrosine kinase, KDR

Gene therapy for stimulation of angiogenesis